Used for to seek input from a health economist clinical trial design and costings
Post author: mcats. Last update: 25/02/2016 at 3:33 pm by mcats.
It is important to seek input from a health economist in design phase of a study as there are wide variety of economic evaluation methods and techniques that can be employed, including:
Studies that quantify the overall costs associated with different diseases. These costs-of-illness studies are often used in advocacy and outline a problem, but don’t provide a solution.
Used when two interventions produce an equal outcome and so only costs need to be compared.
Applied when both costs and benefits are quantified in monetary terms. It helps predict if the benefits of the policy outweigh its costs and by how much relative to other alternatives.
This is a tool that compares the costs and health effects of an intervention and the results can help inform decision makers in resource allocation.
A form of cost-effectiveness analysis in which outcomes are quality-adjusted on a 0-1 scale, in which 0 is a heath state equivalent to death and 1 is full health.
CASE: Cost-effectiveness of lowering blood pressure with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: an ADVANCE trial-based analysis
An economic evaluation assessing the cost-effectiveness of the routine administration, irrespective of blood pressure (BP), of a fixed-dose combination of perindopril and indapamide to patients with type 2 diabetes mellitus. It involved an analysis alongside Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) trial, an international, multicentre, randomised controlled trial of 11,140 participants with type 2 diabetes. Read the full article: https://www.mja.com.au/journal/2010/193/6/cost-effectiveness-lowering-blood-pressure-fixed-combination-perindopril-and
|Please contact us for a quote|